NAD turns Iceberg Labs over to federal regulators regarding Immune Shield claims
NEW YORK — The National Advertising Division of the Council of Better Business Bureaus on Tuesday referred advertising claims made by Iceberg Labs for its Immune Shield dietary supplement to the Federal Trade Commission and Food and Drug Administration for further review.
The advertising at issue was challenged before NAD, the advertising industry’s self-regulatory forum, by the Council for Responsible Nutrition.
One of the claims Iceberg Labs makes is that its supplements are preventive of any form of influenza, a potential sore spot for FTC regulators. During the H1N1 pandemic, the FTC publicly warned companies that “unless they have scientific proof for their claims, they are violating federal law and must drop the claims or face further action.” In collaboration with other enforcement agencies, including the FDA, the FTC then pledged to aggressively work to identify, investigate and take additional regulatory and law enforcement action against individuals or businesses that deceptively promote purported H1N1 products.
Iceberg Labs’ “magic pill” also purports to serve as a weight-loss aid. The company also suggested that its products may prevent cancer. Following NAD’s initial inquiry, the advertiser contacted NAD but did not submit supporting evidence for its claims.
NAD noted in its decision that it was disappointed that the advertiser did not participate in NAD’s inquiry, “particularly in light of the strong health claims being made, including claims that the product will ‘fortify’ the immune system, prevent ‘any form of flu’ and, most troubling, claims suggesting that this supplement will help prevent and eliminate cancer.”
Based on the advertiser’s failure to respond to NAD’s inquiry, pursuant to Section 2.9 of the NAD/NARB Procedures, NAD will refer this matter to the FTC and FDA for further review.
No comments found
Save-A-Tooth product recommended as part of first aid kit
WAYNE, Pa. — Phoenix-Lazerus recently announced that both the National Institutes of Health and the Mayo Clinic now recommend the company’s Save-A-Tooth product be included as part of any first aid kit.
Phoenix-Lazarus offers a “The Complete First Aid Kit” on Amazon for $24.95. Invented by a dentist, the Save-A-Tooth is a six-part system that protects knocked-out teeth.
According to the company, more than 5 million teeth are knocked out each year in the United States.
Double Pump tapped for LipiGesic-M marketing efforts
SCHOFIELD, Wis. — In preparation for a retail launch, PuraMed BioScience on Monday announced it has entered into an agreement with Double Pump to enhance marketing efforts and product awareness surrounding the company’s homeopathic analgesic LipiGesic-M.
"We have retained Double Pump to assist us in our marketing campaign for LipiGesic-M, which will include a search for a high-profile spokesperson for the product, as well as introduction to various sales channels," stated PuraMed CEO Russell Mitchell. "We believe Double Pump’s experience with international brands, as well as their relationships with highly recognizable celebrities and athletes, makes them an excellent choice as a partner in launching LipiGesic-M on the national level and building awareness of the product to the level of becoming a household name."
PuraMed also stated it recently submitted a clinical study supporting the efficacy of LipiGesic M to an unnamed medical journal for peer review.
No comments found